Announcement on Pegpesen's New Indication Obtaining Drug Clinical Trial Approval Notice

About this update from Xiamen Amoytop Biotech Co., Ltd. Class A

Announcement on Pegpesen's New Indication Obtaining Drug Clinical Trial Approval NoticeThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Xiamen Amoytop Biotech Co., Ltd. Class A